Evidence map›Paper›PMID 34006319›Full record

ArticleInfectious diseases of poverty2021

Lymphatic filariasis elimination endgame in an urban Indian setting: the roles of surveillance and residual microfilaremia after mass drug administration.

Anjali Modi, Keshav G Vaishnav, Kailash Kothiya, Neal Alexander

Open access · goldAbstract read
In one paragraph

Article in Infectious diseases of poverty, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Accelerating Progress Towards the 2030 Neglected Tropical Diseases Targets: How Can Quantitative Modeling Support Programmatic Decisions?Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Article
  7. Combinations of the azaquinazoline anti-Frontiers in microbiology · 2024
    Article
  8. Article
  9. Prevalence of Lymphatic Filariasis based on Morbidity and Healthcare-seeking Practices of Patients in a Gram Panchayat of Paschim Burdwan District, West Bengal.Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Anjali ModiDepartment of Community Medicine, Government Medical College, Surat, Gujarat, India.ORCID https://orcid.org/0000-0002-2058-0722
Keshav G VaishnavVector Borne Disease Control (VBDC) Department, Surat Municipal Corporation, Surat, Gujarat, India.
Kailash KothiyaVector Borne Disease Control (VBDC) Department, Surat Municipal Corporation, Surat, Gujarat, India.
Neal AlexanderMRC International Statistics and Epidemiology Group, London School of Hygiene and Tropical Medicine, London, UK. neal.alexander@lshtm.ac.uk.ORCID http://orcid.org/0000-0002-6707-7876
Sardar Vallabhbhai National Institute of Technology Surat · INGovernment Medical College · INLondon School of Hygiene & Tropical Medicine · GB

Funding

Medical Research Council MR/K012126/1Medical Research Council MR/R010161/1
6 · The paper itself

Abstract

backgroundTo secure the gains of lymphatic filariasis (LF) elimination programs, attention is needed to the 'residual microfilaremia phase', in which high-risk populations may be crucial. The present study documents the impact of mass drug administration (MDA) in the urban Indian setting of Surat City, with high rates of in-migration.

methodsEpidemiological assessment included National Filaria Control Program (NFCP) and World Health Organization recommended routine and pre-MDA microfilaremia surveys respectively. Routine filaria surveys were conducted around the year in approximately 2000-4000 people per month, while pre-MDA surveys were carried out annually among approximately 4000 people from four fixed and four random sites. In 2016, Transmission Assessment Survey (TAS) was done in primary school children. The outcomes were microfilaremia (Mf) and antigen prevalence; more specifically, microfilaremia according to place of birth, in pre-MDA and routine night blood smears (NBS) collected from 2008 to 2015. Prevalence ratios and confidence intervals were calculated.

resultsA total of 25 480 pre-MDA and 306 198 routine NBS were examined during the study. In 2008, the Mf prevalence in the routine survey was 63/18 814 (0.33%), declining to 23/39 717 (0.06%) in 2016. Pre-MDA surveys showed a similar decrease from 47/4184 (1.1%) in 2008 to 12/4042 (0.3%) in 2015. In those born outside Surat, microfilaremia decreased below transmission thresholds, but remained more than treble that of the remainder of the population, in both the pre-MDA surveys [prevalence ratio: 3.17, 95% confidence interval (CI): 1.15-8.72], and the routine surveys (3.31, 95% CI: 1.47-7.48). Though the TAS results indicated that MDA endpoints had been reached, sub-group analysis identified that 90% of antigenemic children were from families of high-risk groups.

conclusionsExtensive long-term epidemiological monitoring suggests that all the urban population, including high-risk groups, have benefitted from the ELF program. To prevent re-establishment of infection in large urban areas with unsanitary conditions conducive to filarial vector breeding, there is need to identify residual microfilaremia by customized surveys in addition to pre-MDA monitoring and TAS. The present findings can be used to develop strategies to prioritize screening, surveillance and plan treatment of high-risk groups after achieving MDA endpoints.

Indexed as

Elephantiasis, FilarialFilaricidesAnimalsChildEpidemiological MonitoringHumansMass Drug AdministrationPrevalenceWuchereria bancroftiFilaricidesEliminationEpidemiologicalLymphatic filariasisMass drug administrationMigrationResidual microfilaremiaSurveillanceUrban

Identifiers

PMID34006319
PMCPMC8130313
OpenAlexW3163179906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.